« Dendreon's Provenge Passes Medicare Panel | Main | Merck Scores Coup with its CETP Inhibitor at AHA Meeting »

11/18/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0134892cf549970c

Listed below are links to weblogs that reference Actelion May Fetch $9.8 Billion in Amgen Deal:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

More from Fierce Biotech on how analysts are valuating a company like Actelion in setting the expected deal price
http://www.fiercebiotech.com/story/how-do-you-price-biotech-company-actelion/2010-11-18?utm_medium=rss&utm_source=rss

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada